Genetic & Genomic MedicineDiagnostic Microbiology and Infectious DiseasePeer-reviewed
Y380Q novel mutation in receptor-binding domain of SARS-CoV-2 spike protein together with C379W interfere in the neutralizing antibodies interaction
Ivaine Taís Sauthier Sartor, Fernanda Hammes Varela, Mariana Rost Meireles…·COVIDa study group
The paper identifies a novel Y380Q mutation in the SARS-CoV-2 spike protein RBD, along with C379W, which may interfere with neutralizing antibody binding in early pandemic variants.
5 citations